Postprandial lipaemia and vascular disease
The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: In this review we discuss the postprandial pathophysiological mechanisms that promote vascular disease, the evidence for a role of postprandial lipaemia (PPL) in vascular disease and the effect of modifiable and nonmodifiable factors in PPL. RECENT FINDINGS: PPL refers to the dynamic changes in serum lipids and lipoproteins (mainly in serum triglycerides) that occur after a fat load or a meal. Recent data indicate that postprandial or nonfasting triglyceride levels are better predictors of cardiovascular risk, suggesting that efficiency of postprandial handling of triglyceride-rich lipoproteins plays a role in the causation of vascular disease. SUMMARY: The recent finding that postprandial serum triglyceride levels are even better than fasting serum triglyceride levels as predictors of vascular disease indicate that it is better to measure an index of triglyceride-rich lipoproteins (in most cases serum triglyceride levels) in the postprandial period than in the postabsorptive fasting state. Moreover, by the time the postabsorptive state is reached, some of these proatherogenic triglyceride-rich lipoprotein changes may be missed in the measurement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alternatively, the higher VLDL-TG concentrations in men (69, 129) may compete for access to LPL, thereby delaying chylomicron clearance (103, 130).”
From Sex differences in the metabolism of glucose and fatty acids by adipose tissue and skeletal muscle in humans (2025) · cites this paper as [129]
Citations
Cites
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228 · cited 1×
“Effect of postprandial lipaemia on nonlipoprotein proatherogenic events/processes Atherosclerosis is recognized as an inflammatory disease [26,27] and evidence is gathering on several fronts that postprandial TRL may promote a proinflammatory vascular state, likely induced by TRL lipolytic products through activation…”
BackgroundNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · cited 3×
“The relationship between PPL and CHD has been known since 1950, but two more decades were needed to document (after Zilversmit [73]) that CMR play an important role in the process of”
BackgroundFasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · cited 1×
“Data from the Reykjavik Study and European Prospective Investigation of Cancer Norfolk Study [2] were incorporated into a meta-analysis of 27 additional prospective studies in Western populations comprised of 7 262 525 participants, including 10 158 CHD cases.”
MethodRemnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 806
Inflammation in Atherosclerosis: Transition From Theory to Practice
Libby, P., Okamoto, Y., Rocha, V. Z., & Folco, E. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0706 · Cited by 799 · cited 1×
“These lesions have been demonstrated to increase production of inflammatory cytokines such as interleukin 6 [32–36] and tumour necrosis factor-a (TNF-a) and metalloproteinases [37].”
Background
Research works printed but not linked: 3
- Wierzbicki, 2012, Triglycerides: a case for treatment Curr Opin C, ardiol, 27, 398
- Goldberg, 2011, Triglycerides and heart disease: still a hypothesis Arterioscler Thromb Vasc B, iol, 31, 1716
- Ooi, 2001, Postprandial remnant-like lipoproteins in hypertriglyceridemia., J Clin Endocrinol Metab, 86, 3134
Cited by
Non-alcoholic fatty liver disease and dyslipidemia: An update
Katsiki, N., Mikhailidis, D. P., & Mantzoros, C. S. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.003 · Cited by 564
Glycemic Variability and Oxidative Stress: A Link between Diabetes and Cardiovascular Disease?
Saisho, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018381 · Cited by 195
“In addition to hyperglycemia-induced oxidative stress, postprandial dyslipidemia, mainly triglyceridemia, may also contribute to vascular damage and CVD [55].”
BackgroundMicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
Solly, E. L., Dimasi, C. G., Bursill, C. A., Psaltis, P. J., & Tan, J. T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122199 · Cited by 69
“Mechanistic studies demonstrate that, although CM and VLDL are too large for passage into the arterial intima, their smaller cholesterol-enriched remnants can penetrate the vascular subendothelial space, driving a pro-inflammatory state in the endothelium and promoting monocyte recruitment and monocyte/macrophage accu…”
BackgroundCosta, D. N., Santosa, S., & Jensen, M. D. (2025) · Physiological Reviews · doi:10.1152/physrev.00008.2024 · Cited by 34
Influence of type of dairy matrix micro- and macrostructure on in vitro lipid digestion
Schmidt, J. M., Kjølbæk, L., Jensen, K. J., Rouy, E., Bertram, H. C., Larsen, T., Raben, A., Astrup, A. V., & Hammershøj, M. (2020) · Food & Function · doi:10.1039/d0fo00785d · Cited by 28
Physiological Responses to Hypoxia on Triglyceride Levels
Morin, R., Goulet, N., Mauger, J., & Imbeault, P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730935 · Cited by 32
“…fasting, the activation of the sympathetic nervous system (SNS) and the secretion of stress hormones facilitate the intracellular breakdown of TG within AT, which favor the efflux of non-esterified fatty acids (NEFA) into the circulation (Lafontan and Langin, 2009; Young and Zechner, 2013).”
BackgroundRole of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
López-Pedrera, C., Barbarroja, N., Patiño-Trives, A. M., Luque-Tévar, M., Torres-Granados, C., Aguirre, M. A., Collantes‐Estévez, E., & Pérez‐Sánchez, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062012 · Cited by 34
Pérez‐Martínez, P., Alcala-Diaz, J. F., Kabagambe, E. K., García‐Ríos, A., Tsai, M. Y., Delgado‐Lista, J., Kolovou, G. D., Straka, R. J., Gómez-Delgado, F., Hopkins, P. N., et al. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.05.009 · Cited by 35
Self-citationWong, T. H. T., Wong, C. H., Zhang, X., Zhou, Y., Xu, J., Yuen, K. C., Wan, J. M. F., & Louie, J. C. Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa132 · Cited by 27
Kjølbæk, L., Schmidt, J. M., Rouy, E., Jensen, K. J., Astrup, A. V., Bertram, H. C., Hammershøj, M., & Raben, A. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab220 · Cited by 26
Pradeilles, R., Norris, T., Sellem, L., & Markey, O. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.09.003 · Cited by 24
“As the majority of the day is spent in the postprandial state [21,27], and the postprandial handling of TG may be a better CVD risk predictor than fasting TG concentrations [73], understanding of the postprandial lipid responses to meals varying in dairy matrix structure is of importance.”
BackgroundLim, S. K., Kim, Y. J., Khang, A. R., & Eckel, R. H. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.09.004 · Cited by 26
Xu, J. R., Chen, Y., Zhao, S., & Liu, L. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1146-9 · Cited by 24
Koopal, C., Marais, A. D., Westerink, J., van der Graaf, Y., & Visseren, F. L. J. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076901 · Cited by 21
“poproteins, while TC and LDL-C change little (24).”
Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
Guan, Y., Hou, X., Tian, P., Ren, L., Tang, Y., Song, A., Zhao, J., Gao, L., & Song, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.646185 · Cited by 14
“Typically, serum lipid levels are monitored in the fasting state, but many studies have confirmed that postprandial TG levels are closely related to various diseases such as atherosclerosis (1), coronary heart disease (2), and type 2 diabetes (3).”
BackgroundXu, J. R., Qu, P., Du, X., Xiang, Q., Guo, L., Zhu, L., Tan, Y., Fu, Y. H. H., Wen, T., & Liu, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.685385 · Cited by 15
“Hypertriglyceridemia represents the increased number of triglyceride-rich lipoproteins (TRLs) and their remnant lipoproteins (RLPs) in the circulation (4, 5).”
BackgroundEscudero‐López, B., Cerrillo, I., Ortega, Á., Martín, F., & Fernández‐Pachón, M. (2022) · Foods · doi:10.3390/foods11091256 · Cited by 14
“Postprandial TG levels are known as risk predictors of coronary heart disease [76,77], and delayed clearance of TG-rich lipoproteins (postprandial hyperlipidemia) is associated with the development of atherosclerosis [78].”
BackgroundCoelho, R. C. L. A., Hermsdorff, H. H. M., Gomide, R. S., Alves, R. D. M., & Bressan, J. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000229 · Cited by 12
“TGrich lipoproteins and their remnants are known as risk predictors of coronary heart disease (1-2).”
BackgroundMaraki, M. I., & Sidossis, L. S. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00245.2015 · Cited by 15
“Recent detailed reviews have highlighted the clinical importance of PPL (12, 37).”
BackgroundO’Hara, C., Ojo, B. A., Emerson, S. R., Simenson, A. J., Peterson, S., Perkins-Veazie, P. M., Payton, M. E., Hermann, J., Smith, B. J., & Lucas, E. A. (2019) · Nutrition and Metabolic Insights · doi:10.1177/1178638819869946 · Cited by 9
“The discrepancies between results could be due to the (1) type of meal consumed; a lipid load elicited a much higher oxidative stress response when compared to a meal of all three macronutrients, (2) physical fitness; physically active individuals exhibited significant increases in SOD compared to inactive participant…”
ResultFerreira, T. D. S., Antunes, V. P., Leal, P. M., Sanjuliani, A. F., & Klein, M. R. S. T. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002525 · Cited by 10
Postprandial lipid profile in patients with type 2 diabetes
Katsiki, N., & Kolovou, G. D. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.842545 · Cited by 8
Self-citationThe accuracy of four formulas for LDL-C calculation at the fasting and postprandial states
Xu, J. R., Du, X., Zhang, S., Xiang, Q., Zhu, L., & Liu, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.944003 · Cited by 9
“The elevated level of lowdensity lipoprotein cholesterol (LDL-C) is concerned as one of the main risk factors of CVD, especially for atherosclerotic CVD (2).”
BackgroundBiomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study
Kolovou, V., Diakoumakou, O., Papazafiropoulou, A. K., Katsiki, N., Fragopoulou, E., Vasiliadis, I. K., Degiannis, D., Duntas, L. H., Antonopoulou, S., & Kolovou, G. D. (2018) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401812010059 · Cited by 5
Self-citationMulet-Cabero, A.-I., & Brodkorb, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-56909-9_8 · Cited by 4
Rebolledo-Cobos, R., Rodero, E. M. A., Yepes-Charris, Y., Iriarte, T. P., Esmeral, L. P. M., Becerra, J. E., & Sarmiento-Rubiano, L. A. (2022) · Retos · doi:10.47197/retos.v47.94874 · Cited by 3
“…acute or chronic effects of resistance training (RT) associated primarily with muscle strength and endurance adaptations (Rebolledo-Cobos et al., 2014; Castro et al., 2019; Fernandez et al., 2020), on postprandial metabolic markers in postmenopausal women (Zotou et al., 2010; Kolovou & Ooi 2013).”
BackgroundThe impact of dairy matrix structure on postprandial lipid responses
Kjølbæk, L., & Raben, A. (2023) · Proceedings of The Nutrition Society · doi:10.1017/s0029665123003622 · Cited by 1
Role of Milk Intake in Modulating Serum Lipid Profiles and Gut Metabolites
Xu, T., Zhang, C., Yang, Y., Huang, L., Liu, Q., Li, L., Zeng, Q., & Li, Z. (2024) · Metabolites · doi:10.3390/metabo14120688 · Cited by 1
“Institutional Review Board Statement: This animal study protocol was approved by the Animal Experiment Ethics Committee of Guangxi University (GXU-2023-0034).”
Identification and characterization of biomarkers in atherosclerosis and diabetes
Nieddu, G., LEPEDDA, A. J., & FORMATO, M. (2014) · UnissResearch (Università degli Studi di Sassari)
Postprandial Hyperlipemia is an Indication for Additional Risk in Sitosterolemia
Ito, M., & Ikewaki, K. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed104
Rebolledo-Cobos, R., Caro-Freile, A. I., Polo-Gallardo, R., Jurado-Castro, V., Jabba-Molinares, E., Herazo-Beltrán, Y., Mendinueta-Martínez, M., & Sarmiento-Rubiano, L. A. (2019) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v67n2.66844
NAMIKI, Y., KIMURA, S., SASAKI, R., Homma, Y., Miyajima, C., Kasahara, F., Kuwabara, A., & Ogihara, T. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.467
Metadata
- Authors
- Kolovou, G., & Ooi, T. C.
- Affiliations
- Onassis Cardiac Surgery Center (GR)
- University of Ottawa (CA)
- Corresponding author
- Kolovou, Genovefa
- Venue
- Current Opinion in Cardiology
- Published
- 2013-07
- Volume
- 28
- Issue
- 4
- Pages
- 446-451
- ISSN
- 0268-4705 (ISSN-L)
- OpenAlex
- W2094230156
- Cited by
- 32
- References
- 87
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1
- FWCI
- 0.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- postprandial lipemia, vascular disease, postprandial triglycerides, triglyceride-rich lipoproteins, cardiovascular risk prediction, atherogenesis, postprandial lipoprotein metabolism
- MeSH terms
- Humans, Hyperlipidemias, Life Style, Risk Factors, Triglycerides, Vascular Diseases, Postprandial Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.